Tiziana Life Sciences Ltd (NASDAQ:TLSA) price closed higher on Friday, January 10, and jumping 14.13% above its previous close.
A look at the daily price movement shows that the last close reads $0.74, with intraday deals fluctuated between $0.81 and $0.95. The company’s 5Y monthly beta was ticking 0.178. Taking into account the 52-week price action we note that the stock hit a 52-week high of $1.74 and 52-week low of $0.41. The stock subtracted -16.83% on its value in the past month.
Tiziana Life Sciences Ltd, which has a market valuation of $92.95 million, is expected to release its quarterly earnings report in February.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give TLSA a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Sell.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 1 analysts have assigned TLSA a recommendation rating as follows: 0 rate it as a Hold; 1 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Tiziana Life Sciences Ltd (TLSA) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that TLSA’s price is at present 5.21% off the SMA20 and -6.34% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 52.27, with weekly volatility standing at 9.21%. The indicator jumps to 11.00% when calculated based on the past 30 days. Tiziana Life Sciences Ltd (NASDAQ:TLSA)’s beta value is holding at 0.68, while the average true range (ATR) indicator is currently reading 0.09.
An analysis of the Tiziana Life Sciences Ltd (NASDAQ:TLSA) stock in terms of its daily trading volume indicates that the 3-month average is 322.35K. However, this figure increases on the past 10-day timeline to an average of 0.48 million.
Current records show that the company has 102.27M in outstanding shares. The insiders’ percentage holdings are 35.15% of outstanding shares while the percentage share held by institutions stands at 1.75%. The stats also highlight that short interest as of 2024-12-13, stood at 0.17 million shares, which puts the short ratio at the time at 0.64. From this we can glean that short interest is 26.00 of company’s current outstanding shares. Notably, we see that shares short in December fall slightly given the previous month’s figure stood at 0.27 million. But the 20.65% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
